Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Dermatology · Glucose-6-phosphate dehydrogenase (G6PD) deficiency

Why Do I Need a G6PD Test Before Starting Dapsone?

At a Glance

A G6PD blood test is required before starting dapsone to ensure your red blood cells can safely process the medication. If you lack the protective G6PD enzyme, taking dapsone can cause a severe and rapid breakdown of red blood cells known as hemolytic anemia.

Dapsone is a highly effective medication for treating the intense, itchy rash of dermatitis herpetiformis, but before your doctor can prescribe it, they must ensure your red blood cells can handle the medication. Dapsone causes a type of chemical stress in the bloodstream known as oxidative stress [1]. Your body uses a specific enzyme called G6PD (glucose-6-phosphate dehydrogenase) to protect your red blood cells from this exact type of stress [2][3]. The G6PD blood test checks to see if your body makes enough of this protective enzyme. If you are deficient, taking dapsone could cause your red blood cells to break down rapidly—a severe and potentially life-threatening condition called hemolytic anemia [1][4]. The test results usually take a few days to return, during which time your doctor may suggest topical creams to help manage the itching.

The Role of the G6PD Enzyme

G6PD (glucose-6-phosphate dehydrogenase) is an enzyme that helps red blood cells function normally and defends them against harmful substances [2]. Some people are born with a genetic condition called G6PD deficiency, meaning their bodies produce lower amounts of this enzyme, or the enzyme doesn’t work as effectively as it should [4].

Most people with G6PD deficiency experience absolutely no symptoms in their daily lives and are usually unaware they have the condition. However, when exposed to certain triggers—such as infections, fava beans, or specific “oxidative” medications like dapsone—their unprotected red blood cells can become rapidly damaged and destroyed [1][3].

Note: If you are diagnosed with G6PD deficiency, you will need to avoid these triggers for life, regardless of how you treat your dermatitis herpetiformis.

The Risk of Hemolytic Anemia

If a person with low G6PD levels takes dapsone, the medication’s breakdown products (such as dapsone hydroxylamine) attack the unprotected red blood cells [1]. This triggers hemolytic anemia, a dangerous condition where red blood cells are destroyed much faster than the bone marrow can replace them [1][5].

Symptoms of acute hemolytic anemia can appear suddenly and may include:

  • Extreme fatigue, dizziness, and weakness
  • Pale or yellowish skin and eyes (jaundice)
  • Dark, tea-colored urine
  • Shortness of breath and rapid heartbeat

Because this reaction can be so severe, checking your G6PD levels is a mandatory safety measure before you can begin taking dapsone [4]. If the test shows you are deficient, your doctor will discuss alternative oral medications that can help control the blistering rash safely while you wait for your gluten-free diet to take effect [6].

Monitoring Your Blood During Treatment

If your G6PD blood test comes back normal, your doctor can safely prescribe dapsone. However, even with normal G6PD levels, you will still need regular blood tests while taking the medication.

Dapsone naturally causes a mild, generally manageable amount of red blood cell breakdown in almost everyone who takes it [7][8]. It can also lead to a related condition called methemoglobinemia, where your blood temporarily carries oxygen less effectively [5]. Symptoms of this condition include shortness of breath, fatigue, and cyanosis—a bluish or grayish tint to the lips, skin, or nail beds.

Because of these expected side effects, your doctor will monitor your complete blood counts (CBC) frequently to ensure your body is tolerating the medication well and to adjust your dosage if necessary [5][6]. This usually involves weekly or biweekly lab tests during the first month of treatment, eventually stretching out to every few months once your body adjusts to the medication.

Common questions in this guide

What can I do for the intense itching while waiting for my G6PD test results?
Your doctor may prescribe or recommend specific topical creams to help soothe the intense itching of your dermatitis herpetiformis rash while you wait for your blood test results to come back.
What happens if my G6PD levels are too low to take dapsone?
If your blood test shows a G6PD deficiency, your doctor will discuss alternative oral medications that can safely control your skin symptoms while you wait for a gluten-free diet to take full effect.
Why do I still need regular blood tests if my G6PD results are normal?
Even with normal G6PD levels, dapsone can cause mild red blood cell breakdown and a related condition called methemoglobinemia. Regular blood counts ensure your body is tolerating the medication safely and help your doctor adjust the dose if needed.
What are the signs of a severe reaction to dapsone?
Symptoms of a severe reaction like hemolytic anemia include extreme fatigue, yellowing of the skin or eyes, dark tea-colored urine, shortness of breath, and a bluish tint to the lips. You should seek emergency care immediately if you notice these signs.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What can I use to soothe the intense itching while I wait for my G6PD test results to come back?
  2. 2.If I am found to have a G6PD deficiency, which alternative medication do you recommend for my skin symptoms?
  3. 3.What is the exact schedule for blood monitoring during my first few months on dapsone?
  4. 4.How quickly should I contact you or seek emergency care if I notice dark urine or a bluish tint to my lips once I start taking the medication?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (8)
  1. 1

    Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.

    Dziewulska KH, Reisz JA, Hay AM, et al.

    The Journal of pharmacology and experimental therapeutics 2023; (386(3)):323-330 doi:10.1124/jpet.123.001634.

    PMID: 37348965
  2. 2

    Blister and bite cells in G6PD deficiency.

    Opsahl M, Chen W

    International journal of laboratory hematology 2022; (44(1)):55-56 doi:10.1111/ijlh.13689.

    PMID: 34431226
  3. 3

    Molecular Mechanisms of Drug-Induced Hemolysis in G6PD Deficiency: Mechanistic Insights.

    Paika S, Machini M, Parmar MS

    Oxidative medicine and cellular longevity 2025; (2025()):7041213 doi:10.1155/omcl/7041213.

    PMID: 40799291
  4. 4

    Dapsone induced hemolysis in a patient with Hansen's disease and G6PD deficiency: A preventable peril.

    Ghorui AK, Patra PK

    Clinical case reports 2022; (10(4)):e05700 doi:10.1002/ccr3.5700.

    PMID: 35498357
  5. 5

    Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.

    Hu Y, Geere M, Awan M, et al.

    Hematology (Amsterdam, Netherlands) 2022; (27(1)):1253-1258 doi:10.1080/16078454.2022.2149943.

    PMID: 36444994
  6. 6

    Dapsone Toxicity in Relapsing Polychondritis: Methemoglobinemia and Concomitant Hemolytic Anemia.

    Magalhães JN, Monteiro A

    Cureus 2026; (18(1)):e101910 doi:10.7759/cureus.101910.

    PMID: 41728517
  7. 7

    Hematological alterations in lepromatous leprosy: A cross-sectional observational study.

    Gupta B, Gupta S, Chaudhary M, et al.

    Disease-a-month : DM 2020; (66(7)):100919 doi:10.1016/j.disamonth.2019.100919.

    PMID: 31796205
  8. 8

    A case of DAPSONE INDUCED METHEMOGLOBINEMIA.

    Mahmood N, Khan MU, Haq IUL, et al.

    Journal of pharmaceutical policy and practice 2019; (12()):22 doi:10.1186/s40545-019-0185-y.

    PMID: 31249693

This page provides educational information about G6PD testing and dapsone treatment for dermatitis herpetiformis. It does not replace professional medical advice, diagnosis, or treatment from your dermatologist or healthcare provider.

Get notified when new evidence is published on Dermatitis herpetiformis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.